Zhengye Biotechnology Holding (ZYBT) Operating Leases (2025)
Zhengye Biotechnology Holding (ZYBT) posted quarterly Operating Leases of $46104.6 for Q4 2025.
Zhengye Biotechnology Holding (ZYBT) Operating Leases (2025) Analysis & Trends
Zhengye Biotechnology Holding (ZYBT) has reported Operating Leases for 1 consecutive years, with $46104.6 the latest figure, recorded in Q4 2025.
- In Q4 2025, Operating Leases changed N/A year-over-year to $46104.6; the TTM figure through Dec 2025 stood at $46104.6 (changed N/A YoY), while the FY2025 annual figure was $47000.0, changed N/A from the prior year.
- Operating Leases was little changed at $46104.6 in Q4 2025 per ZYBT's latest filing.
- Across five years, Operating Leases topped out at $46104.6 in Q4 2025 and bottomed at $46104.6 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Zhengye Biotechnology Holding | 88.82 Mn | 81.50 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 46,104.58 |